The future of best investing in vaccines: the Health Technology Assessment approach

Maria Lucia Specchia, Gualtiero Ricciardi, Giuseppe La Torre, Chiara De Waure, Giacomina Chiaradia, Alice Mannocci, Nicola Nicolotti

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)

Abstract

Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.
Lingua originaleEnglish
pagine (da-a)1609-1610
Numero di pagine2
RivistaVACCINE
Volume26
DOI
Stato di pubblicazionePubblicato - 2008

Keywords

  • Biomedical Technology
  • Drug Industry
  • Health Care Costs
  • Health Expenditures
  • Humans
  • Infection Control
  • Vaccines

Fingerprint Entra nei temi di ricerca di 'The future of best investing in vaccines: the Health Technology Assessment approach'. Insieme formano una fingerprint unica.

Cita questo